All In Biotech

Drug Trial Radar · NCT07685769

A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

AN OPEN-LABEL MULTICENTER STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF RIMEGEPANT 75 MG ODT FOR ACUTE TREATMENT OF MIGRAINE IN ADULT PARTICIPANTS IN INDIA WITH PREVIOUS INSUFFICIENT RESPONSE TO TRIPTANS

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jul 24, 2026

Primary completion

Jan 4, 2028

Study completion Jan 4, 2028

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jul 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, single-arm, open-label Phase 4 study evaluating the safety and tolerability of rimegepant 75 mg orally disintegrating tablet (ODT) for the acute treatment of migraine (with or without aura) in adult patients in India who have had an insufficient response, intolerance, or contraindication to triptans. It will enroll approximately 60 participants.

Conditions

  • Acute Treatment of Migraine

Interventions

  • Rimegepant 75 mg ODTDrug

    Rimegepant 75 mg ODT (1 tablet) PRN at the time of migraine attack

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-emergent adverse events (TEAEs)Time frame: Up to 28 days
  2. Incidence of Serious adverse events (SAEs)Time frame: up to 28 days

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Visakha Institute Medical Sciences

    Visakhapatnam, Andhra Pradesh, India · Recruiting

  • Artemis Hospital

    Gurugram, Haryana, India · Recruiting

  • BGS Global Institute of Medical Sciences

    Bangalore, Karnataka, India · Recruiting

  • Mallikatta Neuro Centre

    Mangalore, Karnataka, India · Recruiting

  • Chopda Medicare & Research Centre Pvt. Ltd: Magnum Heart Institute

    Nashik, Maharashtra, India · Recruiting

  • Bhaktivedanta Hospital & Research Institute

    Thane, Maharashtra, India · Recruiting

  • Bangur Institute of Neurosciences, IPGME&R - SSKM Hospital

    Kolkata, West Bengal, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.